Fulcrum Therapeutics

FULCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$296.796 M

$3.89 +3.18%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$74.9M

Loss-making

Shares outstanding

76,297,257

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#235Vanda PharmaceuticalsVNDA$300.7M
#236Zentalis PharmaceuticalsZNTL$300.4M
#237Fulcrum TherapeuticsFULC$296.8M
#238Bicycle TherapeuticsBCYC$291.9M
#239ImmuneeringIMRX$291.8M

Where these numbers come from

Share counts and financials for Fulcrum Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.